These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2415424)

  • 1. [Disorders of hemoglobin synthesis and erythrocytic enzyme activity in myeloproliferative hemoblastoses].
    Tkhe LKh; Soboleva SS
    Gematol Transfuziol; 1985 Oct; 30(10):26-30. PubMed ID: 2415424
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin abnormalities in neoplastic hematological disorders.
    Walker IR; Ali MA
    Can Med Assoc J; 1973 Apr; 108(7):843-7. PubMed ID: 4513360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The total and isoenzyme-lactate dehydrogenase content of plasma, leukocytes and erythrocytes in myeloproliferative diseases].
    Helbig W; Parthum K; Sommer HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(3):229-37. PubMed ID: 4106013
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.
    Rachmilewitz B; Rachmilewitz M
    Isr J Med Sci; 1977 Jul; 13(7):710-5. PubMed ID: 270474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of various erythrocytic anomalies in leukemia].
    Zittoun R; Bernadou A; Leclerc M; Pouillart P; Soria J; Cosson G; Vagner D; Bilski-Pasquier G; Bousser J
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):215-9. PubMed ID: 5266627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemoglobinogenesis in myeloid leukemias and preleukemias in adults. Analysis of 65 cases].
    Calabuig T; Pérez Piño MT; Sánchez Fayos J; Outeiriño J; Rodríguez MA; Serrano D; Lite M; Figuera A
    Sangre (Barc); 1983; 28(3):294-302. PubMed ID: 6194565
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigations on the activity of glycolytic erythrocytic enzymes in polycythemia vera.
    Zatoński W; Kwiatkowska J; Baranowski T; Tawlas N
    Pol Med J; 1971; 10(4):819-22. PubMed ID: 4256716
    [No Abstract]   [Full Text] [Related]  

  • 8. Foetal erythropoiesis in human leukaemia.
    Weatherall DJ; Clegg JB; Wood WG; Callender ST; Sheridan BL; Pritchard J
    Nature; 1975 Oct; 257(5528):710-2. PubMed ID: 810726
    [No Abstract]   [Full Text] [Related]  

  • 9. [The behavior of HbF and of erythrocytic G6PD in leukosis].
    Rea F; Di Tullio MT; Marchi C
    Pediatria (Napoli); 1970; 78(1):44-51. PubMed ID: 5268250
    [No Abstract]   [Full Text] [Related]  

  • 10. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal to fetal erythropoiesis in acute myelogenous leukemia.
    Gupta AD; Vakil RF; Aga R; Shetty PA
    Indian J Cancer; 1983; 20(3):166-8. PubMed ID: 6197353
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical identification of adult and fetal haemopoiesis in the spleen in lymphoma, leukaemia and myeloproliferative disease.
    Underwood JC; Dangerfield VJ
    J Pathol; 1981 May; 134(1):71-80. PubMed ID: 6169819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The fetal hemoglobin switch in neonatal erythrocytes fractioned on a density gradient].
    Masala B; Demuro P; Formato M; Manca L
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):278-82. PubMed ID: 9704122
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of erythroid precursor cells. Hemoglobin quantitation in single clones by radioimmunoassay.
    Dean A; Schechter AN; Papayannopoulou T; Stamatoyannopoulos G
    J Biol Chem; 1981 Mar; 256(5):2447-53. PubMed ID: 6161934
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquired disorders of hemoglobin.
    Bradley TB; Ranney HM
    Prog Hematol; 1973; 8():77-98. PubMed ID: 4522922
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoglobin switching activity: target cells and direct evidence for a role of environment to cell interactions in Hb F to Hb A switching.
    Papayannopoulou T; Nakamoto B; Kurachi S; Stamatoyannopoulos G
    Trans Assoc Am Physicians; 1983; 96():252-60. PubMed ID: 6208667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glycosaminoglycans in leukocytes in myeloproliferative disorders].
    Kharchenko MF; Shatskaia TL; Ostroumova SS; Rybakova LP; Shcherbakova EG
    Vopr Med Khim; 1984; 30(4):86-91. PubMed ID: 6594825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of the hemoglobin switch in cultures in neonate erythroid precursors by adult cells.
    Vainchenker W; Testa U; Dubart A; Beuzard Y; Breton-Gorius J; Rosa J
    Blood; 1980 Sep; 56(3):541-8. PubMed ID: 6157444
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemoglobin switching: a new experimental model.
    Nienhuis AW
    J Lab Clin Med; 1978 Jun; 91(6):857-61. PubMed ID: 77301
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of circulating megakaryocytes in chronic myeloproliferative syndromes.
    Hanganu E; Iordăcheanu L; Popa G
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(3):377-8. PubMed ID: 6587496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.